CVE-2022-48222 describes an elevation of privilege vulnerability in Acuant AcuFill SDK prior to version 10.22.02.03. During SDK installation, a standard user can exploit an unhidden, elevated certutil.exe window to gain a SYSTEM command prompt, leading to arbitrary code execution. This vulnerability is rated as HIGH severity (CVSS 7.8) due to its low attack complexity and the complete compromise potential, allowing for full confidentiality, integrity, and availability impact. Currently, there is no known active exploitation, publicly available exploit code (Metasploit, Nuclei, ExploitDB), or significant community discussion or media coverage surrounding this CVE.
| Vendor | Product | Version(s) | CPE |
|---|---|---|---|
< 10.22.02.03CPE matchmatch criteria | cpe:2.3:a:gbgplc:acuant_acufill_sdk:*:*:*:*:*:*:*:* |
CVSS version used by this source: 3.1
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
The average CVE in this peer group has 0.0 Twitter, 0.1 Reddit, 0.2 Bluesky, 0.1 Mastodon, and 0.2 GitHub mentions.
No media coverage found for this CVE.
The average CVE in this peer group has 0.3 InfoSec Media, 0.0 Vendor Blog, and 0.0 Security Researcher mentions.
Remediation records are not available for this CVE.